Author:
Ganguly Samayita,Elbayoumi Tamer
Reference22 articles.
1. Lillie JW, O’Keefe M, Valinski H, Hamlin HA Jr, Varban ML, Kaddurah-Daouk R (1993) Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors. Cancer Res 53:3172–3178
2. Miller EE, Evans AE, Cohn M (1993) Inhibition of rate of tumor growth by creatine and cyclocreatine. Proc Natl Acad Sci U S A 90:3304–3308
3. Martin KJ, Chen SF, Clark GM, Degen D, Wajima M, Von Hoff DD, Kaddurah-Daouk R (1994) Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumor cells. J Natl Cancer Inst 86:608–613
4. Martin KJ, Winslow ER, Kaddurah-Daouk R (1994) Cell cycle studies of cyclocreatine, a new anticancer agent. Cancer Res 54:5160–5165
5. Wyss M, Kaddurah-Daouk R (2000) Creatine and creatinine metabolism. Physiol Rev 80:1107–1213